[Federal Register Volume 78, Number 145 (Monday, July 29, 2013)]
[Notices]
[Page 45592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-17945]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[License No. 02/02-0662]


DeltaPoint Capital IV, LP;

    Notice Seeking Exemption Under Section 312 of the Small Business 
Investment Act, Conflicts of Interest
    Notice is hereby given that DeltaPoint Capital IV, L.P., 45 East 
Avenue, 6th Floor, Rochester, NY 14604, Federal Licensees under the 
Small Business Investment Act of 1958, as amended (``the Act''), in 
connection with the financing of a small concern, has sought an 
exemption under Section 312 of the Act and Section 107.730, Financings 
which Constitute Conflicts of Interest of the Small Business 
Administration (``SBA'') Rules and Regulations (13 CFR 107.730). 
DeltaPoint Capital IV, L.P. provided financing to BioMaxx, Inc., 1 
Fishers Road, Suite 160, Pittsford, NY 14534. The financing was 
contemplated for working capital.
    The financing is brought within the purview of Sec.  107.730(a)(1) 
of the Regulations because DeltaPoint Capital IV (New York), L.P., an 
Associate of DeltaPoint Capital IV, L.P., owns more than ten percent of 
BioMaxx, Inc.
    Therefore, this transaction is considered a financing of an 
Associate requiring an exemption. Notice is hereby given that any 
interested person may submit written comments on the transaction within 
fifteen days of the date of this publication to the Acting Associate 
Administrator for Investment, U.S. Small Business Administration, 409 
Third Street SW., Washington, DC 20416.

    Dated: July 15, 2013.
Pravina Raghavan,
Acting Associate Administrator for Investment & Innovation.
[FR Doc. 2013-17945 Filed 7-26-13; 8:45 am]
BILLING CODE 8025-01-M